Recombinant multi-species DGKB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DGKB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Diacylglycerol kinases (DGKs) are regulators of the intracellular concentration of the second messenger diacylglycerol (DAG) and thus play a key role in cellular processes. Nine mammalian isotypes have been identified, which are encoded by separate genes. Mammalian DGK isozymes contain a conserved catalytic (kinase) domain and a cysteine-rich domain (CRD). The protein encoded by this gene is a diacylglycerol kinase, beta isotype. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]
The Alternative Names of target: 6430574F24,90 kDa diacylglycerol kinase,90kda,C630029D13Rik,DAG kinase beta,DAGK2,DGK,DGK-BETA,DGK-beta,DGKB,Dagk,Dgkb,Diacylglycerol kinase beta,Diglyceride kinase beta (DGK-beta),mKIAA0718

Target products collectionGo to DGKB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6023-Ag-1/ GM-Tg-hg-IP6023-Ag-2 Human DGKB protein Human
GM-Tg-rg-IP6023-Ag-1/ GM-Tg-rg-IP6023-Ag-2 Rat DGKB protein Rat
GM-Tg-mg-IP6023-Ag-1/ GM-Tg-mg-IP6023-Ag-2 Mouse DGKB protein Mouse
GM-Tg-cynog-IP6023-Ag-1/ GM-Tg-cynog-IP6023-Ag-2 Cynomolgus/Rhesus macaque DGKB protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6023-Ag-1/ GM-Tg-felg-IP6023-Ag-2 Feline DGKB protein Feline
GM-Tg-cang-IP6023-Ag-1/ GM-Tg-cang-IP6023-Ag-2 Canine DGKB protein Canine
GM-Tg-bovg-IP6023-Ag-1/ GM-Tg-bovg-IP6023-Ag-2 Bovine DGKB protein Bovine
GM-Tg-equg-IP6023-Ag-1/ GM-Tg-equg-IP6023-Ag-2 Equine DGKB protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6023-Ag-1/ GM-Tg-hg-IP6023-Ag-2; GM-Tg-rg-IP6023-Ag-1/ GM-Tg-rg-IP6023-Ag-2;
GM-Tg-mg-IP6023-Ag-1/ GM-Tg-mg-IP6023-Ag-2; GM-Tg-cynog-IP6023-Ag-1/ GM-Tg-cynog-IP6023-Ag-2;
GM-Tg-felg-IP6023-Ag-1/ GM-Tg-felg-IP6023-Ag-2; GM-Tg-cang-IP6023-Ag-1/ GM-Tg-cang-IP6023-Ag-2;
GM-Tg-bovg-IP6023-Ag-1/ GM-Tg-bovg-IP6023-Ag-2; GM-Tg-equg-IP6023-Ag-1/ GM-Tg-equg-IP6023-Ag-2
Products Name DGKB protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DGKB
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DGKB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.